Gene expression-based prediction of pazopanib efficacy in sarcoma-Reference-Cited by-同舟云学术

Gene expression-based prediction of pazopanib efficacy in sarcoma

Published:2022-09 Issue: Volume:172 Page:107-118
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Heilig Christoph E.^ORCID,Laßmann Andreas,Mughal Sadaf S.^ORCID,Mock Andreas,Pirmann Sebastian,Teleanu Veronica,Renner Marcus,Andresen Carolin^ORCID,Köhler Bruno C.,Aybey Bogac^ORCID,Bauer Sebastian^ORCID,Siveke Jens T.,Hamacher Rainer,Folprecht Gunnar,Richter Stephan,Schröck Evelin,Brandts Christian H.,Ahrens Marit,Hohenberger Peter,Egerer Gerlinde,Kindler Thomas,Boerries Melanie,Illert Anna L.,von Bubnoff Nikolas,Apostolidis Leonidas^ORCID,Jost Philipp J.,Westphalen C. Benedikt,Weichert Wilko,Keilholz Ulrich,Klauschen Frederick,Beck Katja,Winter Ulrike,Richter Daniela,Möhrmann Lino,Bitzer Michael,Schulze-Osthoff Klaus,Brors Benedikt^ORCID,Mechtersheimer Gunhild,Kreutzfeldt Simon^ORCID,Heining Christoph,Lipka Daniel B.^ORCID,Stenzinger Albrecht,Schlenk Richard F.,Horak Peter^ORCID,Glimm Hanno,Hübschmann Daniel,Fröhling Stefan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Rare cancers are not so rare: the rare cancer burden in Europe;Gatta;Eur J Cancer,2011

2. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up;Casali;Ann Oncol Official J European Soc Medical Oncol,2018

3. Minimal increase in survival throughout the years in patients with soft tissue sarcoma with synchronous metastases: results of a population-based study;Vos;Oncol,2019

4. ANNOUNCE: a randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) + olaratumab versus dox + PBO in patients (pts) with advanced soft tissue sarcomas (STS);Tap;J Clin Oncol,2019

5. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial;Seddon;Lancet Oncol,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful pazopanib treatment of undifferentiated pleomorphic sarcoma with coamplification of PDGFRA, VEGFR2 and KIT: A case report;Molecular and Clinical Oncology;2024-07-29

2. Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine;Current Treatment Options in Oncology;2024-04-24

3. Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study;European Journal of Cancer;2023-12